CytomX Therapeutics (CTMX) Capital Expenditures (2014 - 2025)
CytomX Therapeutics (CTMX) reported Capital Expenditures of $201000.0 for Q4 2025, up 190.54% on a YoY basis from $69181.4 in Q4 2024, and up 258.27% quarter-over-quarter from -$127000.0 in Q3 2025.
CytomX Therapeutics (CTMX) Capital Expenditures (2014 - 2025) Analysis & Trends
CytomX Therapeutics has reported Capital Expenditures for 12 years, with the latest figure at $201000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 190.54% year-over-year to $201000.0; the trailing twelve-month figure through Mar 2026 stood at $101000.0 (up 741.67% YoY), and the FY2025 full-year result was $220000.0, up 2650.0% from the prior year.
- Capital Expenditures for Q4 2025 stood at $201000.0, up from -$127000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.3 million in Q3 2021, with the low at -$1.6 million in Q4 2022.
- Historically, Capital Expenditures has averaged $134150.0 across 5 years, with a median of $117000.0 in 2024.
- The largest YoY upside for Capital Expenditures was 245.07% in 2021 against a maximum downside of 2608.11% in 2021.
- CytomX Therapeutics' Capital Expenditures stood at $245000.0 in 2021, then plunged by 733.47% to -$1.6 million in 2022, then jumped by 117.14% to $266000.0 in 2023, then plunged by 183.46% to -$222000.0 in 2024, then soared by 190.54% to $201000.0 in 2025.
- The last three Capital Expenditures figures came in at $201000.0 (Q4 2025), -$127000.0 (Q3 2025), and $27000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 201,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Sep 30, 2025 | -127,000.00 |
| Sep 30, 2025 | -127,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | -222,000.00 |
| Dec 31, 2024 | -222,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 266,000.00 |
| Dec 31, 2023 | 266,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |